Department of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.
Department of Pathology, Rede D'OR- São Luiz, São Paulo, Brazil.
Cytopathology. 2020 Jan;31(1):41-46. doi: 10.1111/cyt.12780.
The Paris system for reporting urinary cytology (TPS) was published in order to provide clear cytomorphological criteria for urine cytology specimens, focusing on high-grade urothelial lesions. The aim of this study was to evaluate the impact of implementing TPS and to correlate with available concomitant histological samples, accessing overall sensitivity and specificity.
A retrospective analysis of urine cytology reports from 2017 to 2018 using TPS was carried out, with histological correlation to concomitant samples (up to 3 months). Statistical analysis was performed with calculation of sensitivity and specificity, positive and negative predictive values and risk of malignancy (ROM) for all TPS categories.
A total of 1660 specimens were evaluated. Histological specimens were available for 611 (36.8%) cases. Urine cytology categorised by TPS had 2.4% non-diagnostic cases, 87.1% negative for high-grade urothelial carcinoma (HGUC), 4.6% atypical urothelial cells, 2.7% suspicious for HGUC, 2.7% HGUC and 0.5% cases of other malignancies. Sensitivity, specificity, negative predictive value and positive predictive value were 40.0%, 99.3%, 88.2% and 92.3%, respectively. ROM of each category was 0% for non-diagnostic, 11.1% for negative for HGUC, 32.4% for atypical, 64.9% for suspicious for HGUC and 87.9% for HGUC and other malignancies.
Our findings indicated that implementation of TPS provided a high specificity and predictive positive value for the detection of high-grade urothelial lesions, with proportionally increasing ROMs as categories progress from negative to positive.
巴黎尿细胞学报告系统(TPS)的发布是为了为尿细胞学标本提供明确的细胞形态学标准,重点是高级别尿路上皮病变。本研究旨在评估实施 TPS 的影响,并与可用的同期组织学样本相关联,评估总体敏感性和特异性。
对 2017 年至 2018 年使用 TPS 的尿细胞学报告进行回顾性分析,并与同期样本(最多 3 个月)进行组织学相关性分析。使用 TPS 对所有分类进行统计分析,计算敏感性和特异性、阳性和阴性预测值以及所有 TPS 分类的恶性风险(ROM)。
共评估了 1660 例标本。有 611 例(36.8%)有组织学标本。TPS 分类的尿细胞学有 2.4%的非诊断病例、87.1%的高级别尿路上皮癌(HGUC)阴性、4.6%的非典型尿路上皮细胞、2.7%的 HGUC 可疑、2.7%的 HGUC 和 0.5%的其他恶性肿瘤病例。敏感性、特异性、阴性预测值和阳性预测值分别为 40.0%、99.3%、88.2%和 92.3%。每个分类的 ROM 分别为非诊断的 0%、HGUC 阴性的 11.1%、非典型的 32.4%、HGUC 可疑的 64.9%和 HGUC 和其他恶性肿瘤的 87.9%。
我们的研究结果表明,实施 TPS 为检测高级别尿路上皮病变提供了高特异性和阳性预测值,随着从阴性到阳性的分类进展,ROM 比例递增。